FDA approves at-home COVID-19 test kit that doesn't require a prescription


The Food and Drug Administration has authorized a COVID-19 test kit for use at home with no need for a prescription.
The FDA announced Wednesday it has granted emergency use authorization to LabCorp's Pixel COVID-19 Test Home Collection Kit, which is the first such at-home coronavirus test kit that doesn't require a prescription, CNN and The Washington Post report.
"While many home collection kits can be prescribed with a simple online questionnaire, this newly authorized direct-to-consumer collection kit removes that step from the process, allowing anyone to collect their sample and send it to the lab for processing," Dr. Jeff Shuren, the director of the FDA's Center for Devices and Radiological Health, said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A nasal swab sample can be self-collected using the kit and sent to LabCorp for testing, with positive results being provided over the phone and negative results being provided either through email or an online portal, the FDA said. Previously, the FDA granted emergency use authorization to the Lucira COVID-19 All-In-One Test Kit, but that requires a prescription, CNN notes.
"With this authorization, we can help more people get tested, reduce the spread of the virus and improve the health of our communities," LabCorp Diagnostics Chief Medical Officer and President Dr. Brian Caveney said.
LabCorp said the kit is available through its website to adults and that this FDA approval will allow it to "potentially distribute the kit through retail channels" as well.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Are AI lovers replacing humans?
Talking Points A third of Gen Z singles use tech as a 'romantic companion'
-
What are the Trump Accounts for kids and how do they work?
The Explainer Parents will soon be able to open tax-advantaged investment accounts on their child's behalf
-
'This comes with policy implications'
Instant Opinion Opinion, comment and editorials of the day
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths